Načítá se...
Lead-Time Models Should Not Be Used to Estimate Overdiagnosis in Cancer Screening
Lead-time can mean two different things: Clinical lead-time is the lead-time for clinically relevant tumors; that is, those that are not overdiagnosed. Model-based lead-time is a theoretical construct where the time when the tumor would have caused symptoms is not limited by the person’s death. It i...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4139512/ https://ncbi.nlm.nih.gov/pubmed/24590736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-014-2812-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|